-+ 0.00%
-+ 0.00%
-+ 0.00%

RPT-ZELGEN BIOPHARMA <688266.SS> SAYS IT SIGNS STRATEGIC PARTNERSHIP WITH ABBVIE FOR DEVELOPMENT AND COMMERCIALISATION OF ALVELTAMIG

Reuters·12/31/2025 09:42:20

Please log in to view news